IP Library Granted Patent US 8,722,627
Granted Patent B2
US 8,722,627 · App. 13/265,034 · Granted May 13, 2014

Proteasome-activating lightening peptidic hydrolyzates and compositions containing them

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,627
App. No.
13/265,034
Granted
May 13, 2014
Kind
B2
Abstract

A peptidic hydrolyzate enriched in bioactive peptides is disclosed that is a proteasome activator. Cosmetic and pharmaceutical compositions are disclosed that include the peptidic hydrolyzate enriched in bioactive peptides in a physiologically acceptable medium. Also disclosed are methods for depigmenting, lightening and/or whitening the skin and treating hyperpigmentation blemishes as well as cutaneous signs due to photo-aging by administering the cosmetic compositions or pharmaceutical compositions.

Claims (29)

1. A method for depigmenting, lightening and/or whitening the skin or epithelial appendages, the method comprising:

providing a proteasome activating peptidic hydrolyzate comprising bioactive peptides, with a molecular weight of less than 6 kDa, comprising from 3 to 5 amino acids, each bioactive peptide comprising at least one aspartic acid, one cysteine residue, and an arginine residue and corresponding to one of the following sequences:

(SEQ ID NO: 1)

Arg-Asp-Cys-Arg-Arg;

(SEQ ID NO: 2)

Asn-Asp-Cys-Arg-Lys;

(SEQ ID NO: 3)

Asp-Cys-Arg-His;

(SEQ ID NO: 4)

Val-Asp-Cys-Arg;

or

(SEQ ID NO: 5)

Asp-Cys-Arg;

and

topically applying an effective quantity of said peptidic hydrolyzate to the skin or epithelial appendages to be treated.

2. The method according to claim 1 , wherein said peptidic hydrolyzate is from the hydrolysis of plants selected from corn ( Zea mayz L.), pea ( Pisum sativum ), or rice ( Oryza sativa L.).

3. The method according to claim 1 , wherein said peptidic hydrolyzate is from the hydrolysis of yeasts of the Saccharomyces genus.

4. The method according to claim 1 , wherein said peptidic hydrolyzate contains between 0.5 and 5.5 g/l of peptidic nature compounds.

5. The method according to claim 1 , wherein said peptidic hydrolyzate increases proteasome activity and improves degradation by proteasome of damaged proteins involved in melanogenesis.

6. The method according to claim 1 , wherein said peptidic hydrolyzate further treats hyperpigmentation blemishes selected from the group consisting of melasma, chloasma, actinic lentigo, solar lentigo, ephelides, accidental hyperpigmentation blemishes, post-scarring hyperpigmentation blemishes, and combinations thereof.

7. The method according to claim 1 , wherein said peptidic hydrolyzate treats cutaneous signs of a hyperpigmentary nature due to photo-aging.

8. The method according to claim 1 , wherein said peptidic hydrolyzate is in a cosmetic composition.

9. The method according to claim 3 , wherein said peptidic hydrolyzate is from the hydrolysis of yeasts of the Saccharomyces cerevisiae species.

10. The method according to claim 8 , wherein said peptidic hydrolyzate is present in the cosmetic composition in a quantity representing from 0.0001% to 20% of the total weight of the composition.

11. The method according to claim 8 , wherein the cosmetic composition further comprises one or more solvents selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, white petroleum jelly, vegetable oil, and combinations thereof, said peptidic hydrolyzate being solubilized therein.

12. The method according to claim 8 , wherein the cosmetic composition further comprises at least one additional active principle promoting the action of said peptidic hydrolyzate.

13. The method according to claim 12 , wherein said additional active principle is an agent presenting an activity in the field of lightening agents; soothing agents, organic or inorganic photo-protective agents, moisturizing agent; depigmenting agents, tyrosinase inhibitors, agent stimulating the synthesis of dermal or epidermal macromolecules and/or preventing their degradation; agents stimulating the proliferation of fibroblasts and/or keratinocytes or stimulating keratinocyte differentiation; agents acting on the energy metabolism of cells; depigmenting peptides, plant hydrolyzates, anti-ageing agents, and mixtures thereof.

14. The method according to claim 8 , wherein the peptidic hydrolyzate is present in the cosmetic composition in a quantity representing from 0.05% to 5% of the total weight of the composition.

15. The method according to claim 8 , wherein said cosmetic composition is in a form suitable for topical application comprising a cosmetically acceptable medium.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 028867/0934 →